SCHEMBL4477801

SCHEMBL4477801

CN=C(NC#N)SC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4477799 1.00
SCHEMBL11087989 0.75
SCHEMBL9534597 0.75 ALDH1A1 (0.47)
SCHEMBL11087993 0.75
SCHEMBL11304948 0.72 ALDH1A1 (0.58)
SCHEMBL11477546 0.70 ALDH1A1 (0.56)
SCHEMBL11219198 0.70 ALDH1A1 (0.56)
SCHEMBL10718854 0.70 ALDH1A1 (0.56)
SCHEMBL10718860 0.70 ALDH1A1 (0.56)
SCHEMBL15413419 0.69 ALDH1A1 (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116249701-B Substituted di (pyridin-2-yl) amine derivatives, compositions and pharmaceutical uses thereof 上海海雁医药科技有限公司 2025-05-30 CN disclosed
CN-116249701-A Substituted di (pyridin-2-yl) amine derivatives, compositions and pharmaceutical uses thereof 上海海雁医药科技有限公司 2023-06-09 CN disclosed
US-10174046-B2 SHIP1 modulators and methods related thereto AQUINOX PHARMACEUTICALS (CANADA) INC. (CA) 2019-01-08 US disclosed
US-20180155359-A9 SHIP1 MODULATORS AND METHODS RELATED THERETO TARO PHARMACEUTICALS INC. (CA) 2018-06-07 US disclosed
US-20170362250-A1 SHIP1 MODULATORS AND METHODS RELATED THERETO AQUINOX PHARMACEUTICALS (CANADA) INC (CA) 2017-12-21 US disclosed
US-9765085-B2 SHIP1 modulators and methods related thereto AQUINOX PHARMACEUTICALS (CANADA) INC. (CA) 2017-09-19 US disclosed
US-20170247389-A2 SHIP1 MODULATORS AND METHODS RELATED THERETO TARO PHARMACEUTICALS INC. (CA) 2017-08-31 US disclosed
US-20160031899-A1 SHIP1 MODULATORS AND METHODS RELATED THERETO AQUINOX PHARMACEUTICALS CANADA INC (CA) 2016-02-04 US disclosed
US-8268835-B2 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same PFIZER INC. (US) 2012-09-18 US disclosed
US-7622605-B2 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same PFIZER INC. (US) 2009-11-24 US disclosed
US-4119781-A Process for preparing 4-substituted imidazole compounds SK&F LAB CO. (US) 1978-10-10 US disclosed
US-4104382-A (((THIAZOLYL-, ISOTHIAZOLYL- OR PYRIDYLALKYL)THIO)ALKYL)GUANIDINE SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1978-08-01 US disclosed
US-4104472-A Imidazolemethylphosphonium salts SMITHKLINE CORPORATION (US) 1978-08-01 US disclosed
US-4070475-A THIOALKYL-, AMINOALKYL-, AND OXYALKYL- SUBSTITUTED GUANIDINES SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1978-01-24 US disclosed
US-4063023-A Process for preparing 4-(hydroxymethyl)imidazole compounds SK&F LAB CO. (US) 1977-12-13 US disclosed
US-4049669-A Process for preparing 5-(alkoxy- and aminoethyl thio)methylthiazole compounds SMITHKLINE CORPORATION (US) 1977-09-20 US disclosed
US-4024271-A INHIBITORS OF HISTAMINE ACTIVITY SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1977-05-17 US disclosed
US-4022797-A PHARMACEUTICALS SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1977-05-10 US disclosed
US-4000302-A ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1976-12-28 US disclosed
US-3950333-A HISTAMINE INHIBITORS, OXYALKYL, THIOALKYL, AMINOALKYL DERIVATIVES SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1976-04-13 US disclosed